M&A Deal Summary

Great Point Partners and Orgenesis Acquires MaSTherCell SA

On March 9, 2015, private equity firm Great Point Partners and Orgenesis, Inc. acquired life science company MaSTherCell SA for 25M USD

Acquisition Highlights
  • This is Great Point Partners’ 6th and Orgenesis’ 1st transaction in the Life Science sector.
  • This is Great Point Partners’ 1st and Orgenesis’ 1st largest (disclosed) transaction.
  • This is Great Point Partners’ 1st and Orgenesis’ 1st transaction in Belgium.
Investment Fate
  • MaSTherCell SA was divested to a strategic buyer in 2020 for 315M USD.

M&A Deal Summary

Date 2015-03-09
Target MaSTherCell SA
Sector Life Science
Buyer(s) Great Point Partners
Orgenesis, Inc.
Deal Type Add-on Acquisition
Deal Value 25M USD

Target

MaSTherCell SA

Gosselies, Belgium
website
MaSTherCell SA (Manufacturing Synergies for Therapeutic Cells) is a technology-driven, customer-oriented Contract Development and Manufacturing Organization (CDMO) specialized in cell therapy development for advanced medicinal products. MaSTherCell was established in 2011 and is based in Gosselies, Belgium.

Search 163,065 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Great Point Partners

Greenwich, Connecticut, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 2003
PE ASSETS 456M USD
SizeMiddle-Market
Type Sector Focused
DESCRIPTION

Great Point Partners is a private investment firm focused on investing in private and public healthcare companies. Great Point's private equity practice invests $7 to $25 million of growth capital in private, growing companies. Specific areas of interest within the healthcare sector includes biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and worker compensation companies. Great Point Partners was formed in 2003 and is based in Greenwich, Connecticut.


DEAL STATS #
Overall 16 of 26
Sector (Life Science) 6 of 10
Type (Add-on Acquisition) 1 of 1
Country (Belgium) 1 of 1
Year (2015) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-12 Connecture, Inc.

Brookfield, Wisconsin, United States

Connecture is a web-based consumer shopping, enrollment and retention platform for health insurance distribution. Connecture offers a personalized health insurance shopping experience that recommends the best fit insurance plan based on an individual’s preferences, health status, preferred providers, medications and expected out-of-pocket costs. Connecture’s customers are health insurance marketplace operators such as health plans, brokers and exchange operators, who must distribute health insurance in a cost-effective manner to a growing number of insured consumers. Connecture’s solutions automate key functions in the health insurance distribution process, allowing its customers to price and present plan options accurately to consumers and efficiently enroll, renew and manage plan members.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-24 Cytovance Biologics, Inc.

Oklahoma City, Oklahoma, United States

Cytovance is a contract manufacturing organization of mammalian and microbial biologics. The company works with biotechnology and pharmaceutical companies in the development and manufacturing of proteins, antibodies, and cell-based therapeutic products. Cytovance supports its customers from clinical development to commercial launch in domestic and international markets.

Sell $206M
Buyer

Orgenesis, Inc.

Germantown, Maryland, United States

website


Category Company
Founded 2008
SectorLife Science
Employees111
Revenue 8M USD (2020)
DESCRIPTION

Orgenesis is a pre-clinical cell therapy and regenerative medicine company that is committed to curing Type 1 Diabetes. Orgenesis was founded in 2008 and is based in Germantown, Maryland.


DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 3
Type (Add-on Acquisition) 1 of 3
Country (Belgium) 1 of 1
Year (2015) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-03 MaSTherCell SA

Gosselies, Belgium

MaSTherCell SA (Manufacturing Synergies for Therapeutic Cells) is a technology-driven, customer-oriented Contract Development and Manufacturing Organization (CDMO) specialized in cell therapy development for advanced medicinal products. MaSTherCell was established in 2011 and is based in Gosselies, Belgium.

Sell $315M